Bahrain Oncology Centre Amongst the First in the World to Offer Ground-breaking Sickle Cell and Transfusion Dependent Thalassemia Gene Therapy

MUHARRAQ, Bahrain, May 22 (Korea Bizwire) — The Bahrain Oncology Centre (BOC) has achieved a significant milestone, becoming amongst the first centres in the World to offer the ground-breaking CASGEVY (exagamglogene-autotemcel or ‘exa-cel’) gene therapy for sickle cell disease (SCD) and transfusion dependent thalassemia (TDT). This achievement follows the BOC’s successful accreditation, recognising its adherence [...]